Comparative synthesis and antimicrobial action of silver nanoparticles and silver nitrate
Source abstract
Abstract
The high wave of antibiotic bacterial resistance has addressed an importance for administration of different antibacterial agents, as silver nanoparticles (Ag NPs). However, many investigators still suffer conflict in the mechanistic antimicrobial action of Ag NPs and Ag+ ions. In this regard, our study investigated the comparative antimicrobial action of different sizes of Ag NPs as 8 (nAg1) and 29 (nAg2) nm, in comparison with silver nitrate (AgNO3) against five different bacterial species; Aeromonas hydrophila (A. hydrophila), Pseudomonas putida (Ps. putida), Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), and Bacillus subtilis (B. subtilis) using agar diffusion assay and minimum inhibitory concentration (MIC). The key role of the size of nanomaterials was detected, as the smaller Ag NPs (nAg1) showed more antimicrobial action than the larger particles. Transmission electron microscopy (TEM) studies demonstrated the different mechanistic antibacterial actions of Ag NPs and AgNO3. The effect of combining Ag NPs with antibiotics was also investigated. Synergistic effect of combining Ag NPs with ampicillin was detected against S. aureus, in a size-dependent manner as well. To summarize, our results point towards the major role played by the size of Ag NPs in their antimicrobial effects and the different toxic mechanisms of actions induced by Ag NPs and AgNO3.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Healthcare and Environmental Waste Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Agnihotri S, Mukherji S, Mukherji S (2014) Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. RSC Adv 4:3974–3983. doi: 10.1039/c3ra44507k10.1039/C3RA44507K ↗
2. Ajitha B, Reddy YAK, Reddy PS (2015) Enhanced antimicrobial activity of silver nanoparticles with controlled particle size by pH variation. Powder Technol 269:110–117. doi: 10.1016/j.powtec.2014.08.04910.1016/j.powtec.2014.08.049 ↗
3. Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M (2011) Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 9(11):1035–1052. doi: 10.1586/eri.11.12110.1586/eri.11.121 ↗
4. Arora S, Jain J, Rajwade JM, Pakinar KM (2008) Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 179(2):93–100. doi: 10.1016/j.toxlet.2008.04.00910.1016/j.toxlet.2008.04.009 ↗
5. Banoee M, Seif S, Nazari ZE, Jafari-Fesharaki P, Shahverdi HR, Moballegh A, Moghaddam KM, Shahverdi AR (2010) ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. J Biomed Mater Res B 93(2):557–561. doi: 10.1002/jbm.b.3161510.1002/jbm.b.31615 ↗
6. Chae YJ, Pham CH, Lee J, Bae E, Yi J, Gu MB (2009) Evaluation of the toxic impact of silver nanoparticles on Japanese medaka (Oryzias latipes). Aquat Toxicol 94(4):320–327. doi: 10.1016/j.aquatox.2009.07.01910.1016/j.aquatox.2009.07.019 ↗
7. Cho K-H, Park J-E, Osaka T, Park S-G (2005) The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim Acta 51(5):956–960. doi: 10.1016/j.electacta.2005.04.07110.1016/j.electacta.2005.04.071 ↗
8. Chudasama B, Vala AK, Andhariya N, Upadhyay RV, Mehta RV (2009) Enhanced antibacterial activity of bifunctional Fe3O4–Ag core-shell nanostructures. Nano Res 2(12):955–965. doi: 10.1007/s12274-009-9098-410.1007/s12274-009-9098-4 ↗
9. Dibrov P, Dzioba J, Gosink KK, Häse CC (2002) Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholera. Antimicrob Agents Chemother 46(8):2668–2670. doi: 10.1128/AAC.46.8.2668-2670.200210.1128/AAC.46.8.2668-2670.2002 ↗
10. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res, Part A 52(4):662–668. doi: 10.1002/1097-4636(20001215)52:4<662:AID-JBM10>3.0.CO;2-310.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
11. Guzmán MG, Dille J, Godet S (2009) Synthesis of silver nanoparticles by chemical reduction method and their antibacterial activity. Int J Chem Biomol Eng 2(3):104–111
12. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YK (2008) Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74(7):2171–2178. doi: 10.1128/AEM.02001-0710.1128/AEM.02001-07 ↗
13. Kim JS, Kuk E, Yu KN, Kim J-H, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH (2007) Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 3(1):95–101. doi: 10.1016/j.nano.2006.12.00110.1016/j.nano.2006.12.001 ↗
14. Kümmerer K (2004) Resistance in the environment. J Antimicrob Chemother 54(2):311–320. doi: 10.1093/jac/dkh32510.1093/jac/dkh325 ↗
15. Kvitek L, Panáček A, Soukupová J, Kolář M, Večeřová R, Prucek R, Holecová M, Zbořil R (2008) Effect of surfactants and polymers on stability and antibacterial activity of silver (NPs). J Phys Chem C 112(15):5825–5834. doi: 10.1021/jp711616v10.1021/jp711616v ↗
16. Li P, Li J, Wu C, Wu Q, Li J (2005) Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16(9):1912–1917. doi: 10.1088/0957-4484/16/9/08210.1088/0957-4484/16/9/082 ↗
17. Li L, Sun J, Li X, Zhang Y, Wang Z, Wang C, Dai J, Wang Q (2012) Controllable synthesis of monodispersed silver nanoparticles as standards for quantitative assessment of their cytotoxicity. Biomaterials 33(6):1714–1721. doi: 10.1016/j.biomaterials.2011.11.03010.1016/j.biomaterials.2011.11.030 ↗
18. Martínez-Castañón GA, Niño-Martínez N, Martínez-Gutierrez F, Martínez-Mendoza JR, Ruiz F (2008) Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 10(8):1343–1348. doi: 10.1007/s11051-008-9428-610.1007/s11051-008-9428-6 ↗
19. Mirzajani F, Ghassempour A, Aliahmadi A, Esmaeili MA (2011) Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol 162(5):542–549. doi: 10.1016/j.resmic.2011.04.00910.1016/j.resmic.2011.04.009 ↗
20. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16(10):2346–2353. doi: 10.1088/0957-4484/16/10/05910.1088/0957-4484/16/10/059 ↗
21. National Committee for Clinical Laboratory Standards (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, 4th edn. Wayne
22. National Committee for Clinical Laboratory Standards (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. NCCLS, 6th edn. Wayne
23. Nguyen VQ, Ishihara M, Mori Y, Nakamura S, Kishimoto S, Hattori H, Fujita M, Kanatani Y, Ono T, Miyahira Y, Matsui T (2013) Preparation of size-controlled silver nanoparticles and chitin-based composites and their antimicrobial activities. J Nanomater 693486:1–7. doi: 10.1155/2013/693486
24. Raissy M, Ansari M (2011) In vitro antimicrobial effect of silver nanoparticles on Lactococcus garvieae and Streptococcus iniae. Afr J Microbiol Res 5(25):4442–4445. doi: 10.5897/AJMR11.875
25. Senekal M (2010) Current resistance issues in antimicrobial therapy. CME 28(2):54–57
26. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed Nanotechnol Biol Med 3(2):168–171. doi: 10.1016/j.nano.2007.02.00110.1016/j.nano.2007.02.001 ↗
27. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D (2007) Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18(22):1–9. doi: 10.1088/0957-4484/18/22/22510310.1088/0957-4484/18/22/225103 ↗
28. Soltani M, Ghodratnema M, Ahari H, Ebrahimzadeh Mousavi HA, Atee M, Dastmalchi F, Rahmanya J (2009) The inhibitory effect of silver nanoparticles on the bacterial fish pathogens, Streptococcus iniae, Lactococcus garvieae, Yersinia ruckeri and Aeromonas hydrophila. Int J Vet Res 3(2):137–142
29. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 275(1):177–182. doi: 10.1016/j.jcis.2004.02.01210.1016/j.jcis.2004.02.012 ↗
30. Van Dong P, Ha CH, Binh LT, Kasbohm J (2012) Chemical synthesis and antibacterial activity of novel-shaped silver nanoparticles. Int Nano Lett 2:1–9. doi: 10.1186/2228-5326-2-910.1186/2228-5326-2-9 ↗